AR105134A1 - VACCINES AGAINST INFLUENZA WITH ANTIGEN COINCIDENCE - Google Patents

VACCINES AGAINST INFLUENZA WITH ANTIGEN COINCIDENCE

Info

Publication number
AR105134A1
AR105134A1 ARP160101919A ARP160101919A AR105134A1 AR 105134 A1 AR105134 A1 AR 105134A1 AR P160101919 A ARP160101919 A AR P160101919A AR P160101919 A ARP160101919 A AR P160101919A AR 105134 A1 AR105134 A1 AR 105134A1
Authority
AR
Argentina
Prior art keywords
viral antigen
antigen
coincidence
egg
vaccines against
Prior art date
Application number
ARP160101919A
Other languages
Spanish (es)
Inventor
R Dormitzer Philip
C Settembre Ethan
Original Assignee
Seqirus Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seqirus Uk Ltd filed Critical Seqirus Uk Ltd
Publication of AR105134A1 publication Critical patent/AR105134A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Composiciones de vacunas contra la influenza, preparaciones e intermediarios relacionados, formulaciones, métodos de producción, métodos de inmunización y uso de los mismos, para lograr una protección inmune mejorada en sujetos humanos. Mas específicamente, se describen vacunas contra la influenza no basadas en huevo, que proveen una coincidencia antigénica mejorada. Reivindicación 22: Una vacuna hibrida, caracterizada porque comprende dos o más componentes seleccionados del grupo que consiste en: (i) un antígeno viral de una preparación basada en huevos; (ii) un antígeno viral de una preparación basada en cultivo celular; (iii) un antígeno viral de una preparación de proteínas recombinantes; y (iv) un replicón de ARN que codifica un antígeno viral.Influenza vaccine compositions, preparations and related intermediaries, formulations, production methods, immunization methods and their use, to achieve improved immune protection in human subjects. More specifically, non-egg-based influenza vaccines are described, which provide an improved antigenic match. Claim 22: A hybrid vaccine, characterized in that it comprises two or more components selected from the group consisting of: (i) a viral antigen from an egg-based preparation; (ii) a viral antigen of a cell culture based preparation; (iii) a viral antigen from a recombinant protein preparation; and (iv) an RNA replicon encoding a viral antigen.

ARP160101919A 2015-06-26 2016-06-24 VACCINES AGAINST INFLUENZA WITH ANTIGEN COINCIDENCE AR105134A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562185532P 2015-06-26 2015-06-26

Publications (1)

Publication Number Publication Date
AR105134A1 true AR105134A1 (en) 2017-09-06

Family

ID=59981600

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101919A AR105134A1 (en) 2015-06-26 2016-06-24 VACCINES AGAINST INFLUENZA WITH ANTIGEN COINCIDENCE

Country Status (1)

Country Link
AR (1) AR105134A1 (en)

Similar Documents

Publication Publication Date Title
CO2018005258A2 (en) Herpes simplex virus vaccine
MX2021006931A (en) Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof.
CO2018005229A2 (en) Respiratory Syncytial Virus Vaccine
CO2018005265A2 (en) Nucleic acid vaccines for varicella-zoster virus
BR112018004242A2 (en) vaccine compositions having increased stability and immunogenicity
CR20180174A (en) NEW PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER
EA201591287A1 (en) VACCINES CONTAINING STABILIZED TRIMMERS OF THE HUMAN IMMUNODEFICIENCY VIRUS VIRUS, AND METHODS OF THEIR USE
CL2019000704A1 (en) Canine adenovirus vectors.
BR112018017307A2 (en) isolated nucleic acid molecule, composition, and methods for inducing an immune response against a Zika virus, for treating an individual, and for preventing a Zika virus infection
EA201590597A1 (en) COW HELPATITIS B VIRUS PROTEIN AND SURFACE ANTIGEN PROTEIN AND CONTAINING THEIR VACCINE
EA201891124A2 (en) NEW FLOURED ADJUVANTS AND DELIVERY SYSTEMS
EA201892735A1 (en) COMPOSITION OF VACCINE AGAINST HIV
AR080111A1 (en) IMMUNIZATION METHODS AND COMPOSITIONS
CL2017003224A1 (en) Vaccine against foot-and-mouth disease virus (fmdv) of recombinant modified vaccinia ankara virus (mva)
ZA202204981B (en) Synthetic chimeric poxviruses
AR115069A1 (en) SYNTHETIC CHEMERIC VACCINE VIRUS
FI3656395T3 (en) Methods and compositions for inducing protective immunity against filovirus infection
EA201990711A1 (en) NEW EHV INSERT SITE ORF70
ECSP18081582A (en) CONSTRUCTS OF LIVE ATTENUATED ALFAVIRUS AND METHODS AND USES OF THEM
AR089995A1 (en) ROTAVIRUS SUBUNITIES VACCINES, METHODS OF PREPARATION AND USE OF THE SAME
MX2019007924A (en) Influenza vaccines.
AR093530A1 (en) VACCINATION ASSISTANT, PREPARATION, AND VACCINES CONTAINING IT
EA202092164A1 (en) NEW EHV WITH INACTIVATED UL18 AND / OR UL8
AR115070A1 (en) STEM CELLS CONTAINING A SYNTHETIC CHIMERICAL VACCINE VIRUS AND METHODS FOR ITS USE
AR105134A1 (en) VACCINES AGAINST INFLUENZA WITH ANTIGEN COINCIDENCE